Intraoperative opioid use is not a risk factor for postoperative nausea and vomiting in patients receiving intravenous patient-controlled analgesia with H1 antihistamines: a retrospective analysis
{"title":"Intraoperative opioid use is not a risk factor for postoperative nausea and vomiting in patients receiving intravenous patient-controlled analgesia with H1 antihistamines: a retrospective analysis","authors":"Takehiko Nagaoka , Yoshinori Nakata , Toshiya Shiga","doi":"10.1016/j.pcorm.2025.100502","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><strong>:</strong> Opioids are generally considered a risk factor for postoperative nausea and vomiting (PONV). However, our clinical experience suggests that intraoperative fentanyl and remifentanil dosages, as well as tramadol use, were not risks of PONV in patients receiving intravenous patient-controlled analgesia (IVPCA) containing fentanyl and an H<sub>1</sub> antihistamine (PCA-H). Additionally, intraoperative use of an H<sub>1</sub> antihistamine does not appear to reduce the incidence of PONV in patients receiving PCA-H. We hypothesized that neither opioid use nor intraoperative H<sub>1</sub> antihistamine use would be associated with PONV in patients receiving PCA-H, and we investigated the incidence of and risk factors for PONV in these patients followng laparoscopic gynecological surgery.</div></div><div><h3>Methods</h3><div><strong>:</strong> We examined the incidence of PONV in patients receiving PCA-H after laparoscopic gynecological surgery under general anesthesia. Patient characteristics, anesthetic factors, and intraoperative prophylactic antiemetics were analyzed through multiple logistic regression to assess their relationships with PONV.</div></div><div><h3>Results</h3><div><strong>:</strong> A total of 1,778 patients were included, with 1,767 (99.4 %) receiving propofol-based anesthesia and 1,719 (96.7 %) received an intraoperative prophylactic antiemetic. Overall incidences of nausea, vomiting, and postoperative antiemetic use were 26.5 %, 8.7 %, 11.0 %, respectively. Intraoperative opioid use (fentanyl, remifentanil dose, or tramadol use) was not a risk factor for PONV. Additionally, intraoperative antihistamine use was ineffective.</div></div><div><h3>Conclusion</h3><div><strong>:</strong> Intraoperative doses of fentanyl, remifentanil, and the tramadol use were not PONV risk factors in patients receiving PCA-H under propofol-based anesthesia. Concurrent use of an intraoperative antihistamine was not associated with a further reduction in PONV among patients receiving PCA-H.</div></div>","PeriodicalId":53468,"journal":{"name":"Perioperative Care and Operating Room Management","volume":"40 ","pages":"Article 100502"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perioperative Care and Operating Room Management","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405603025000433","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0
Abstract
Background
: Opioids are generally considered a risk factor for postoperative nausea and vomiting (PONV). However, our clinical experience suggests that intraoperative fentanyl and remifentanil dosages, as well as tramadol use, were not risks of PONV in patients receiving intravenous patient-controlled analgesia (IVPCA) containing fentanyl and an H1 antihistamine (PCA-H). Additionally, intraoperative use of an H1 antihistamine does not appear to reduce the incidence of PONV in patients receiving PCA-H. We hypothesized that neither opioid use nor intraoperative H1 antihistamine use would be associated with PONV in patients receiving PCA-H, and we investigated the incidence of and risk factors for PONV in these patients followng laparoscopic gynecological surgery.
Methods
: We examined the incidence of PONV in patients receiving PCA-H after laparoscopic gynecological surgery under general anesthesia. Patient characteristics, anesthetic factors, and intraoperative prophylactic antiemetics were analyzed through multiple logistic regression to assess their relationships with PONV.
Results
: A total of 1,778 patients were included, with 1,767 (99.4 %) receiving propofol-based anesthesia and 1,719 (96.7 %) received an intraoperative prophylactic antiemetic. Overall incidences of nausea, vomiting, and postoperative antiemetic use were 26.5 %, 8.7 %, 11.0 %, respectively. Intraoperative opioid use (fentanyl, remifentanil dose, or tramadol use) was not a risk factor for PONV. Additionally, intraoperative antihistamine use was ineffective.
Conclusion
: Intraoperative doses of fentanyl, remifentanil, and the tramadol use were not PONV risk factors in patients receiving PCA-H under propofol-based anesthesia. Concurrent use of an intraoperative antihistamine was not associated with a further reduction in PONV among patients receiving PCA-H.
期刊介绍:
The objective of this new online journal is to serve as a multidisciplinary, peer-reviewed source of information related to the administrative, economic, operational, safety, and quality aspects of the ambulatory and in-patient operating room and interventional procedural processes. The journal will provide high-quality information and research findings on operational and system-based approaches to ensure safe, coordinated, and high-value periprocedural care. With the current focus on value in health care it is essential that there is a venue for researchers to publish articles on quality improvement process initiatives, process flow modeling, information management, efficient design, cost improvement, use of novel technologies, and management.